Henry J. Fuchs - Sep 13, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Sep 13, 2024
Transactions value $
-$1,006,526
Form type
4
Date filed
9/17/2024, 05:54 PM
Previous filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $20.6K +300 +0.15% $68.65 197K Apr 30, 2024 Direct F1
transaction BMRN Common Stock Tax liability -$1.03M -12.1K -6.14% $84.90 185K Sep 13, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.